Search

Your search keyword '"Kulic, L."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Kulic, L." Remove constraint Author: "Kulic, L."
98 results on '"Kulic, L."'

Search Results

1. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.

3. Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch.

5. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

7. Multicenter Analytical Validation of Abeta40 Immunoassays

8. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

10. The central biobank and virtual biobank of BIOMARKAPD: A resource for studies on neurodegenerative diseases

11. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis

16. The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

17. A Practical Guide to Immunoassay Method Validation

18. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

19. Post-ischaemic silencing of p66Shcreduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

20. S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease

21. Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24(-/-) mice. Neurochemical Research (34, 1167-82)

23. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress

24. Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice

25. Genetic ablation of the p66Shcadaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer’s disease

26. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.

27. Hyperhomocysteinemia in Alzheimer's disease: the hen and the egg?

29. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke

30. Genetic ablation of the p66(Shc) adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease

31. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation

32. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration

33. The Night Eating Questionnaire through the lens of the Rasch model.

34. Early β-amyloid accumulation in the brain is associated with peripheral T cell alterations.

35. Comprehensive qualitative evaluation of the first ever full-time online course for medical students in one middle-income country.

36. Mechanisms of amyloid-β34 generation indicate a pivotal role for BACE1 in amyloid homeostasis.

37. Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology.

38. Evidence for Effects of Extracellular Vesicles on Physical, Inflammatory, Transcriptome and Reward Behaviour Status in Mice.

39. SWI and phase imaging reveal intracranial calcifications in the P301L mouse model of human tauopathy.

40. Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease.

41. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.

42. A Practical Guide to the Automated Analysis of Vascular Growth, Maturation and Injury in the Brain.

43. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease.

44. Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury.

45. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.

46. fMRI Reveals Mitigation of Cerebrovascular Dysfunction by Bradykinin Receptors 1 and 2 Inhibitor Noscapine in a Mouse Model of Cerebral Amyloidosis.

47. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.

48. Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia

49. Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study.

50. Multicenter Analytical Validation of Aβ40 Immunoassays.

Catalog

Books, media, physical & digital resources